Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

4.280 -0.360 (-7.76%)
Streaming Delayed Price Updated: 3:14 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
19 20 Next >
GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Announces Proposed Refinancing of First Lien Credit Facilities
From GoodRx Holdings, Inc.
Via Business Wire
The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings
From GoodRx
Via Business Wire
Unveiling 7 Analyst Insights On GoodRx Holdings
 
Via Benzinga
Where GoodRx Holdings Stands With Analysts
 
Via Benzinga
GoodRx Holdings: Q3 Earnings Insights
 
Via Benzinga
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
This healthcare stock making a buzz with 160% growth
Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them. 
Via MarketBeat
Topics Economy
In-Depth Examination Of 4 Analyst Recommendations For GoodRx Holdings
 
Via Benzinga
GoodRx to Participate in Upcoming Investor Conferences
From GoodRx Holdings, Inc.
Via Business Wire
Gene therapy: Why does it cost millions for a single treatment?
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. 
Via MarketBeat
Prescription Drug Discount Provider GoodRx Expects To Build Momentum In 2024, Stock Soars
GoodRx Holdings Inc (NASDAQ: GDRX) provided preliminary Q4 FY23 revenue of $195 million-$197 million, up 6%-7% Y/Y, versus the consensus of $190.77 million. 
Via Benzinga
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results. 
Via Benzinga
GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024
From GoodRx Holdings, Inc.
Via Business Wire
Election Edge: 7 Stocks to Snag Before the 2024 Presidential Race Heats Up
Election stocks include companies at the center of national conversation and those likely to get increased government funding. 
Via InvestorPlace
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Longboard Pharmaceuticals, Inc. 
Via Benzinga
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday. 
Via Benzinga
Topics Stocks
GoodRx Appoints Kelly J. Kennedy to Board of Directors
From GoodRx
Via Business Wire
GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From GoodRx Holdings, Inc.
Via Business Wire
This Analyst With 84% Accuracy Rate Sees Around 22% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
U.S. stocks closed slightly higher on Friday, with the S&P 500 notching gains for the third straight week. The S&P 500 gained 2.2% last week, while the Dow Jones ended the week with a 1.9% gain. 
Via Benzinga
Topics Stocks
GoodRx to Participate in the Evercore ISI HealthCONx Conference
From GoodRx Holdings, Inc.
Via Business Wire
HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
Why GoodRx Holdings Stock Dived by Nearly 19% Today
An unimpressive quarter featuring weak guidance led investors to hit the sell button. 
Via The Motley Fool
Why Is Telemedicine Firm GoodRx's Stock Trading Lower Today?
GoodRx Holdings Inc's (NASDAQ: GDRX) Q3 sales decreased 4% Y/Y to $180.0 million compared to $187.3 million, primarily due to a $10.0 million contract termination payment to a client, partially offset... 
Via Benzinga
GoodRx (GDRX) Q3 2023 Earnings Call Transcript
GDRX earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
GoodRx Reports Third Quarter 2023 Results
From GoodRx Holdings, Inc.
Via Business Wire
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results. 
Via Benzinga
GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide
From GoodRx
Via Business Wire
GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx and Navitus Health Solutions Announce Savings Connect Program to Deliver Lower Prescription Prices for Navitus Members
From GoodRx
Via Business Wire
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.